Search clinical trials for: Mode of insulin administration

Total 5958 results

Medical Research Foundation, The Netherlands

Completed

Intraperitoneal vs Subcutaneous Insulin Administration in Type 1 Diabetes Mellitus (IPvsSC)

Type 1 Diabetes Mellitus

Netherlands
Objectif Recherche Vaccins SIDA

Completed

Safety Study Comparing a Vaccine Transcutaneous Administration to the Intramuscular Route (MANON-05)

HIV Infection | Healthy Volunteers

Germany
Genesis Center for Fertility & Human Pre-Implantation...

Unknown

A Novel Stimulation Protocol and the Conventional Low Dose Step-up and Step Down Regimens

PCOS

Cyprus
University of New Mexico
American Diabetes Association

Completed

Timing of Insulin Before Meals Everyday (TIME)

Type 1 Diabetes

United States
University Hospital Inselspital, Berne
Bern University of Applied Sciences

Completed

MEDPass Trial: MedPass Versus Conventional Administration of Oral Nutritional Supplements

Malnutrition

Switzerland
Medtrum France
Axonal-Biostatem

Not yet recruiting

Evaluation of Security and Efficacy of Medtrum Hybrid Closed Loop System (SEECLOOP)

Type 1 Diabetes

France
Heidelberg University

Unknown

Prospective Influence of Bedtime Insulin Glargine on Mobilization and Function of Endothelial Progenitor Cells

Type 2 Diabetes

Germany
Johns Hopkins University

Terminated

Glycemic Effects of Morning Only, Evening Only or Twice Daily Insulin Glargine in Patients With Type 1 Diabetes

Hypoglycemia | Type 1 Diabetes

United States
University of New Mexico
Sanofi

Completed

Comparative Trial Between 3 Types of Insulin Infusion Protocols

Hyperglycemia

United States
Adocia

Completed

A Trial to Compare BioChaperone Insulin Lispro Formulations With US Approved Humalog® and With EU Approved Humalog® in Patients With Type 1 Diabetes Mellitus

Type 1 Diabetes

Germany
Kinderkrankenhaus auf der Bult

Completed

Comparison of Two Management Systems in Patients With Type 1 Diabetes (Pediatric SmartHome)

Drug Therapy | Patient Care

Germany
Oregon Health and Science University

Not yet recruiting

Two Way Crossover Closed Loop Study Insulin vs Insulin and Pramlintide

Type 1 Diabetes
Pennington Biomedical Research Center

Recruiting

Effect of Pulsatile Hormone Administration on Insulin Action

Insulin Sensitivity

United States
Indonesia University

Unknown

The Efficacy, Safety, and Immunogenicity Study Comparing an Insulin Glargine Biosimilar Sansulin Log-G to Lantus

Diabetes Mellitus

Indonesia
University of Turku
Oulu University Hospital; University of Helsinki; Tampere University

Unknown

Intranasal Insulin for Prevention of Type 1 Diabetes

Type 1 Diabetes

Finland
Corporacion Parc Tauli

Completed

Rule-Based Closed Loop System for Type 1 Diabetes Control

Type 1 Diabetes

Spain
ikfe-CRO GmbH
IKFE Institute for Clinical Research and Development

Unknown

Establishing Cardiovascular Biomarkers to Define Preferred Lantus® Use

Insulin-requiring Type 2 Diabetes Mellitus

Germany
Centre Hospitalier Sud Francilien

Completed

Safety of Closed-loop Hybrid Insulin Administration During Ramadan Fasting in People Living With Type 1 Diabetes (RAMDAM)

Type1diabetes

France
Geropharm

Completed

Efficacy and Safety of Insulin Rinsulin® NPH Compared to Humulin® NPH in Type 2 Diabetes Mellitus Patients

Diabetes Mellitus, Type 2

Russian Federation
Sanofi

Completed

Efficacy and Safety of Insuman Basal/Comb/Rapid in Patients With Type 2 Diabetes (SPIRIT)

Type 2 Diabetes Mellitus

Ukraine
University of Pittsburgh

Completed

Insulin Start Therapy Application With Resources and Training (I-START)

Diabetes Mellitus, Type 2

United States
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

Austria, Switzerland, United Kingdom, Germany, Ireland
Novo Nordisk A/S

Completed

Comparison of Biphasic Insulin Aspart 70/30 Versus Insulin Glargine in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

United States, Puerto Rico
Medical University of Graz

Completed

Correlation Between the Interstitial and Arterial Glucose in Post Surgery Patients

Intensive Care

Austria
Novo Nordisk A/S

Completed

Safety and Efficacy of Insulin Aspart in Subjects With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

United Kingdom, Germany, Austria, Denmark, Norway, Sweden, Switzerland, Finland
Novo Nordisk A/S

Completed

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart and BIAsp 30 in Subjects With Type 2 Diabetes (BOOST)

Diabetes Mellitus, Type 2 | Diabetes

China
University of Maryland, Baltimore

Completed

Early Subcutaneous Insulin Glargine Plus Standard of Care for Treatment of Diabetic Ketoacidosis

Diabetic Ketoacidosis

United States
Medical University of Vienna

Unknown

The Role of IntraNasal Insulin in Regulating HepaTic Lipid COntent in HUMANS (INTO_humans)

Healthy Subjects

Austria
Novo Nordisk A/S

Completed

Efficacy and Safety of NovoMix® 30 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark, Sweden, Norway
Novo Nordisk A/S

Completed

Safety and Effect of Biphasic Insulin Aspart 50 in Patients With Type 2 Diabetes Mellitus.

Diabetes Mellitus, Type 2 | Diabetes

Japan
CPEX Pharmaceuticals Inc.

Completed

Effects of Nasulin Versus Placebo on Blood Glucose Control in Patient Volunteers With Type 2 Diabetes Mellitus (CPEX-011)

Type 2 Diabetes

United States
Assistance Publique - Hôpitaux de Paris

Withdrawn

Detection Medication Administration Errors Using Bar-code and RFID Technology (DREAM) (DREAM)

Medication Administered in Error
Centre Hospitalier Universitaire Dijon

Unknown

TReatment by Insulin Continuous Infusion in Type 2 DIAbetes (TRICIDIA2)

Diabetes

France
Novo Nordisk A/S

Completed

Comparing Efficacy and Safety of Insulin Degludec/Insulin Aspart Twice Daily and Biphasic Insulin Aspart Twice Daily in Subjects With Type 2 Diabetes Mellitus Before, During and After Ramadan

Diabetes Mellitus, Type 2 | Diabetes

United Arab Emirates, Malaysia, India, South Africa, Algeria, Lebanon
Fundación Pública Andaluza Progreso y Salud

Completed

Insulin in Total Parenteral Nutrition (INSUPAR)

Diabetes Mellitus

Spain
Novo Nordisk A/S

Completed

Effect of Biphasic Insulin Compared to Biphasic Insulin Combined With Insulin Aspart, With or Without Metformin in Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Saudi Arabia, Egypt
Diabeloop
AGIR à Dom; Icadom; CHU Grenoble Alpes

Completed

Clinical Data Collection for the Closed Loop Development for the Type 2 Diabetes Treatment - DT2_1 (DT2_1)

Type 2 Diabetes Treated With Insulin

France
Novo Nordisk A/S

Completed

Observational Study of Patients Using NovoRapid® or Soluble Human Insulin for Treatment of Type 2 Diabetes (UPGRADE)

Diabetes Mellitus, Type 2 | Diabetes

Italy
Novo Nordisk A/S

Completed

Efficacy and Safety of Biphasic Insulin Aspart 30 in Type 1 or 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1

China
IKFE Institute for Clinical Research and Development

Completed

Effect of Insulin Glulisine vs Regular Human Insulin on Postprandial Endothelial Function in Type 2 Diabetes

Diabetes Mellitus

Germany
Novo Nordisk A/S

Completed

Comparison of Two Biphasic Insulin Aspart Treatments in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Denmark
Novo Nordisk A/S

Completed

Efficacy and Safety of Insulin Detemir in Combination With Insulin Aspart and Biphasic Insulin Aspart 30 in Type 2 Diabetes (PreFER)

Diabetes Mellitus, Type 2 | Diabetes

Austria, Germany, Switzerland
Emory University
Sanofi; University of Miami

Completed

Basal/Bolus Versus Sliding Scale Insulin In Hospitalized Patients With Type 2 Diabetes

Hyperglycemia | Diabetes

United States
Novo Nordisk A/S

Completed

Investigating Efficacy and Safety of Biphasic Insulin Aspart 50 Twice Daily Versus Biphasic Human Insulin 50 Twice Daily Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes Mellitus

Diabetes Mellitus, Type 2 | Diabetes

China
Novo Nordisk A/S

Completed

Comparison of Two NN5401 Formulations Versus Biphasic Insulin Aspart 30, All in Combination With Metformin in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Poland, Spain, Germany, Finland, France
Novo Nordisk A/S

Completed

Comparison of Two Formulations of Biphasic Insulin Aspart 70

Healthy | Diabetes

United Kingdom
CPEX Pharmaceuticals Inc.

Withdrawn

Intranasal Insulin and Its Effect on Postprandial Metabolism in Comparison to Subcutaneous Insulin

Type 1 Diabetes Mellitus
Novo Nordisk A/S

Completed

Comparison of Insulin Glargine Versus Biphasic Insulin Aspart 30/70 or Biphasic Insulin Aspart 30/70 in Combination With Metformin in Subjects With Type 2 Diabetes.

Diabetes Mellitus, Type 2 | Diabetes

Turkey
Novo Nordisk A/S

Completed

Safety and Efficacy of Biphasic Insulin Aspart 50 in Subjects With Type 2 Diabetes

Diabetes Mellitus, Type 2 | Diabetes

Japan
Novo Nordisk A/S

Completed

Observational Study on the Effect of NovoMix® 30, Levemir® or NovoRapid® (Alone or Combined) in Type 2 Diabetics Previously Treated With Anti-diabetic Medication (A1chieve®)

Diabetes Mellitus, Type 2 | Diabetes

Saudi Arabia, Algeria, Argentina, Bangladesh, China, Egypt, India, Indonesia, Iran, Islamic Republic of, Jordan, Korea, Republic of, Libyan Arab Jamahiriya, Malaysia, Mexico, Morocco, Pakistan, Philippines, Russian Federation and more

3

Subscribe